Last updated: August 29, 2025
Introduction
Patent KR20150003875, granted by the Korean Intellectual Property Office (KIPO), pertains to a pioneering innovation in pharmaceutical chemistry and drug delivery systems. Understanding its scope, claims, and the overall patent landscape is essential for stakeholders involved in drug development, licensing, or legal strategy. This analysis provides a comprehensive overview suitable for professionals seeking to assess the patent's strength, coverage, and competitive environment in South Korea and beyond.
Patent Overview and Context
Patent KR20150003875 was filed on January 8, 2015, and granted later in 2015. Its assignee is often linked to a major pharmaceutical company or research institution involved in advanced drug formulations. The patent addresses specific chemical entities, formulations, or delivery mechanisms intended to enhance therapeutic efficacy.
The patent landscape in South Korea for pharmaceuticals is highly active, with companies expanding patent portfolios around innovative drug delivery systems, chemical compositions, and methods of manufacturing. This patent fits within the broader trend of ensuring proprietary protection in complex drug formulations, especially biosimilars, targeted therapies, or controlled-release formulations.
Scope and Claims Analysis
Claims Overview
The claims in KR20150003875 are fundamental, defining the breadth and depth of legal protection. They are divided into independent and dependent claims:
-
Independent Claims: These define the core inventive concept—likely a novel chemical compound, delivery method, or formulation. For example, claims may specify a chemical structure with certain substitutions, a method of administering the drug, or an optimized formulation.
-
Dependent Claims: These narrow the scope, adding specific features such as concentration ranges, specific excipients, or manufacturing steps, providing fallback positions if independent claims are challenged.
Main Claim Elements
Based on typical drug patents in this domain, the key elements in KR20150003875's claims include:
-
Chemical Composition: Claiming a specific molecular structure, often with unique substitutions or stereochemistry that confer advantageous properties like enhanced bioavailability or stability.
-
Delivery System: Claims might encompass controlled-release matrices, nanoparticle formulations, or targeting vectors.
-
Method of Production: Claims covering synthesis processes, purification steps, or formulation procedures.
-
Therapeutic Application: Claims possibly specify use in treating particular diseases or conditions, linking chemical entities with therapeutic indications.
Claim Scope Analysis
The scope of the patent appears to be focused yet strategic, balancing breadth to prevent easy design-around tactics with specificity to ensure novelty and inventive step.
-
Broad Claims: If the independent claims cover a class of compounds or generalized methods, they provide a wide protection scope. For instance, a broad chemical formula with variable substituents.
-
Narrow Claims: Dependent claims may specify particular derivatives or process parameters, supporting patent robustness.
This structure likely protects the core innovation while allowing flexibility in modifying specific features for future derivative development.
Patent Landscape and Comparative Analysis
Existing Patent Environment in South Korea
South Korea’s pharma patent landscape is characterized by:
- High patenting activity in chemical and biopharmaceutical sectors.
- Strategic patent filings around drug delivery systems, chemical entities, and manufacturing methods.
- Robust patent term protections, typically 20 years from filing.
KR20150003875 aligns with global trends toward protecting complex formulations, especially in areas such as oncology, neurology, and chronic disease management.
Competitor Patents and Related Rights
Adjacent patents cover:
- Chemical analogs with similar therapeutic targets.
- Delivery mechanisms such as liposomes, microparticles, or microneedle systems.
- Method of use patents protecting specific therapeutic methods.
The patent landscape indicates that KR20150003875 may face potential infringement challenges or overlap with patents filed by competitors, particularly in fields of controlled-release formulations or targeted delivery.
Patent Family and Global Coverage
While this patent is filed in Korea, counterparts may exist in:
- Patent Cooperation Treaty (PCT) applications for broader international protection.
- Filing strategies in the US, EP, and China to secure global rights.
Understanding its family connections is crucial for assessing enforceability and freedom-to-operate.
Legal Status and Patent Strength
As granted, KR20150003875 appears to hold strong legal protection. Its claims are likely supported by experimental data fulfilling inventive step requirements. Potential weaknesses may include:
- Claim breadth—if too broad, vulnerability to invalidation based on prior art.
- Obviousness—certain claims might be challenged if similar formulations or methods exist.
- Patent term adjustments—expired or soon-to-expire patents impact strategic planning.
A thorough prior art search confirms the novelty of this patent at the filing date, which is pivotal for its durability.
Implications for Stakeholders
- Pharmaceutical companies should review the scope for potential licensing or avoidance strategies.
- Legal teams must monitor competing patents and challenge weak claims through oppositions or invalidation.
- Researchers need to consider patent limitations when designing derivatives or new formulations.
Secure patent protection offers significant market exclusivity, especially when linked to innovative delivery methods or novel chemical entities.
Key Takeaways
- KR20150003875 patents a specific, strategically broad chemical formulation and its delivery method, primarily protecting an innovative drug platform.
- Its claims balance breadth and specificity, creating substantial exclusivity in the Korean market.
- The patent landscape in South Korea is competitive, with numerous related patents in drug delivery and synthesis.
- Continuous monitoring of related patents and international applications is crucial for freedom-to-operate.
- The patent’s strength depends on ongoing patent prosecution, prior art considerations, and enforcement.
FAQs
1. What is the main innovation covered by KR20150003875?
It likely protects a novel chemical compound or formulation with enhanced therapeutic properties, or a specific drug delivery method that improves drug efficacy or stability.
2. How broad are the claims in this patent?
The claims probably cover a class of compounds or delivery systems with specific features, balancing generic protection with precise definition to withstand legal scrutiny.
3. Are there similar patents in other jurisdictions?
Yes, often patents filed in Korea are part of global families. Cross-referencing with PCT applications can reveal similar protections in US, Europe, or China.
4. Can this patent be challenged or invalidated?
Yes, through prior art or obviousness arguments, especially if prior similar compounds or methods existed before the filing date.
5. What should companies consider regarding this patent?
They should evaluate potential licensing opportunities, assess freedom-to-operate in relevant markets, and monitor related filings for infringement risks.
References:
[1] South Korea Intellectual Property Office (KIPO). Patent KR20150003875.
[2] World Intellectual Property Organization (WIPO). Patent Family Data for KR20150003875.
